Hoffmann, P., Globig, A., Thomann, A. K., Grigorian, M., Krisam, J., Hasselblatt, P., . . . Gauss, A. (2020). Tofacitinib in treatment-refractory moderate to severe ulcerative colitis: Real-world experience from a retrospective multicenter observational study. Journal of Clinical Medicine, 9(7), . https://doi.org/10.3390/jcm9072177
Chicago-Zitierstil (17. Ausg.)Hoffmann, Peter, Anna-Maria Globig, Anne K. Thomann, Maximilian Grigorian, Johannes Krisam, Peter Hasselblatt, Wolfgang Reindl, und Annika Gauss. "Tofacitinib in Treatment-refractory Moderate to Severe Ulcerative Colitis: Real-world Experience from a Retrospective Multicenter Observational Study." Journal of Clinical Medicine 9, no. 7 (2020). https://doi.org/10.3390/jcm9072177.
MLA-Zitierstil (9. Ausg.)Hoffmann, Peter, et al. "Tofacitinib in Treatment-refractory Moderate to Severe Ulcerative Colitis: Real-world Experience from a Retrospective Multicenter Observational Study." Journal of Clinical Medicine, vol. 9, no. 7, 2020, https://doi.org/10.3390/jcm9072177.